Development of a Pharmacodynamic Marker of EWS-FLI1 Activity to Aid in the Clinical Translation of Targeted Therapies for Ewing sarcoma |
Van Andel Research Institute / Patrick Grohar, MD, PhD |
Reach Grants |
2013 |
Michigan |
Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma |
Baylor College of Medicine / Cliona Rooney, PhD |
Reach Grants |
2013 |
Texas |
Accelerating Access to Cellular Therapies for the Treatment of Childhood Malignancies |
Seattle Children’s Hospital and Regional Medical Center / Julie Park, MD |
Phase I/II Infrastructure Grants |
2013 |
Washington |
Children's Hospital of Pittsburgh of UPMC Phase 1-2 Infrastructure Support Grant
|
University of Pittsburgh / Jean Tersak, MD |
Phase I/II Infrastructure Grants |
2013 |
Pennsylvania |
Development of MicroRNA-Nanoparticles to Treat Childhood Acute Leukemia Carrying MLL Rearrangements |
University of Cincinnati College of Medicine / Jianjun Chen, PhD |
Innovation Grants |
2013 |
Ohio |
Engager T cells for the Adoptive Immunotherapy of Pediatric Malignancies |
Baylor College of Medicine / Stephen Gottschalk, MD |
Innovation Grants |
2013 |
Texas |
Multispecific T Cells for Adoptive Immunotherapy of Pediatric High Grade Glioma (HGG) |
Baylor College of Medicine / Nabil Ahmed, MD, MSc |
Innovation Grants |
2013 |
Texas |
An Intersection of Cell Metabolism and Differentiation in Childhood Sarcomas |
Cedars-Sinai Medical Center / Sandra Orsulic, PhD |
Innovation Grants |
2013 |
California |
Novel Targeted Therapies for Rhabdomyosarcoma |
St. Jude Children’s Research Hospital / Michael Dyer, PhD |
Innovation Grants |
2013 |
Tennessee |
Children's Hospital Colorado Experimental Therapeutics Program |
Children’s Hospital Colorado / Lia Gore, MD |
Phase I/II Infrastructure Grants |
2013 |
Colorado |